找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

(版块ONCOLOGY(肿瘤学)版块期刊总数:80)
新窗
投票 ESCI期刊Blood and Lymphatic Cancer-Targets and Therapy 2024/2025影响因子:3.943 (BLOOD LYMPHAT CANCER) (1179-9889). (ONCOLOGY)  ...234
Total Citations:138; 2023 JIF:3.943; JIFRank: 99/322 ; Rank-JIF: 99; Number-of-JIF:322; 5 Year JIF:3.303; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3.9; Immediacy Index:0.6; Immediacy Index-dealt:0.642; 2023 JCI:0.57; JCI Rank: 188/322 ; Total Articles:2; JCI Quartile:Q3; JCI Percentile:41.77; Eigenfactor:0; Normalized Eigenfactor:0.052; Article Influence Score:0.863; JIF Percentile:69.4; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:7; % of Articles in Citable items:0.2857; Cited Half-Life:2.7; Citing Half-Life:6.5; % of OA Gold:1; Publisher name:ELSEVIER SCIENCE INC; Publisher address:STE 800, 230 PARK AVE, NEW YORK, USA, NY, 10169;
投票 ESCI期刊JMIR Cancer 2024/2025影响因子:3.386 (JMIR CANCER) (2369-1999). (ONCOLOGY)(肿瘤学)Emerging Sources Citation Index  ...234
Total Citations:789; 2023 JIF:3.386; JIFRank: 118/322 ; Rank-JIF: 118; Number-of-JIF:322; 5 Year JIF:3.124; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3.2; Immediacy Index:0.3; Immediacy Index-dealt:0.359; 2023 JCI:0.66; JCI Rank: 161/322 ; Total Articles:51; JCI Quartile:Q2; JCI Percentile:50.16; Eigenfactor:0.002; Normalized Eigenfactor:0.376; Article Influence Score:0.979; JIF Percentile:63.5; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:57; % of Articles in Citable items:0.8947; Cited Half-Life:2.8; Citing Half-Life:5.6; % of OA Gold:0.9842; Publisher name:ELSEVIER; Publisher address:RADARWEG 29, AMSTERDAM, Netherlands, 1043 NX;
投票 ESCI期刊Reports of Practical Oncology and Radiotherapy 2024/2025影响因子:1.272 (REP PRACT ONCOL RADI) (1507-1367). (ONCOLOGY)  ...234
Total Citations:1361; 2023 JIF:1.272; JIFRank: 273/322 ; Rank-JIF: 273; Number-of-JIF:322; 5 Year JIF:1.457; 5 Year JIF Quartile:Q4; JIF Without Self Cites:1; Immediacy Index:0.1; Immediacy Index-dealt:0.149; 2023 JCI:0.3; JCI Rank: 274/322 ; Total Articles:72; JCI Quartile:Q4; JCI Percentile:22.3; Eigenfactor:0.001; Normalized Eigenfactor:0.288; Article Influence Score:0.285; JIF Percentile:27.2; JIF Quartile:Q3; AIS Quartile:Q4; Citable Items:86; % of Articles in Citable items:0.8372; Cited Half-Life:5; Citing Half-Life:8.8; % of OA Gold:0.0575; Publisher name:SAGE PUBLICATIONS LTD; Publisher address:1 OLIVERS YARD, 55 CITY ROAD, LONDON, EN
投票 ESCI期刊Journal of Breast Imaging 2024/2025影响因子:2.123 (J BREAST IMAGING) (2631-6110). (ONCOLOGY)(肿瘤学)Emerging Sources Cit  ...234
Total Citations:603; 2023 JIF:2.123; JIFRank: 221/322 ; Rank-JIF: 221; Number-of-JIF:322; 5 Year JIF:1.889; 5 Year JIF Quartile:Q4; JIF Without Self Cites:1.4; Immediacy Index:1.4; Immediacy Index-dealt:1.472; 2023 JCI:0.42; JCI Rank: 232/322 ; Total Articles:58; JCI Quartile:Q3; JCI Percentile:32.11; Eigenfactor:0.001; Normalized Eigenfactor:0.21; Article Influence Score:0.43; JIF Percentile:49.3; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:76; % of Articles in Citable items:0.7632; Cited Half-Life:2.5; Citing Half-Life:6.9; % of OA Gold:0.0833; Publisher name:RUSSIAN PRESIDENTIAL ACAD NATL ECONOMY & PUBLIC ADM (RANEPA); Publisher addres
投票 ESCI期刊Memo-Magazine of European Medical Oncology 2024/2025影响因子:0.405 (MEMO-MAG EUR MED ONC) (1865-5041). (ONCOLOGY)(肿瘤学  ...234
Total Citations:239; 2023 JIF:0.405; JIFRank: 304/322 ; Rank-JIF: 304; Number-of-JIF:322; 5 Year JIF:0.442; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.4; Immediacy Index:0.2; Immediacy Index-dealt:0.245; 2023 JCI:0.1; JCI Rank: 303/322 ; Total Articles:29; JCI Quartile:Q4; JCI Percentile:6.06; Eigenfactor:0; Normalized Eigenfactor:0.068; Article Influence Score:0.092; JIF Percentile:5.7; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:77; % of Articles in Citable items:0.3766; Cited Half-Life:4.2; Citing Half-Life:3.1; % of OA Gold:0.4587; Publisher name:UNIV ILLINOIS PRESS; Publisher address:1325 S OAK ST, MC-566, CHAMPAIGN, Usa, IL, 6
投票 ESCI期刊Cancer Informatics 2024/2025影响因子:2.408 (CANCER INFORM) (NULL). (ONCOLOGY)(肿瘤学)Emerging Sources Citation Index  ...234
Total Citations:792; 2023 JIF:2.408; JIFRank: 193/322 ; Rank-JIF: 193; Number-of-JIF:322; 5 Year JIF:2.365; 5 Year JIF Quartile:Q3; JIF Without Self Cites:2.3; Immediacy Index:0.5; Immediacy Index-dealt:0.582; 2023 JCI:0.54; JCI Rank: 196/322 ; Total Articles:31; JCI Quartile:Q3; JCI Percentile:39.29; Eigenfactor:0; Normalized Eigenfactor:0.109; Article Influence Score:0.484; JIF Percentile:40.2; JIF Quartile:Q3; AIS Quartile:Q4; Citable Items:33; % of Articles in Citable items:0.9394; Cited Half-Life:8.2; Citing Half-Life:6.9; % of OA Gold:0.9111; Publisher name:MDPI; Publisher address:ST ALBAN-ANLAGE 66, BASEL, SWITZERLAND, CH-4052;
投票 ESCI期刊Indian Journal of Medical and Paediatric Oncology 2024/2025影响因子:0.366 (INDIAN J MED PAEDIAT) (0971-5851). (ONCOLO  ...234
Total Citations:779; 2023 JIF:0.366; JIFRank: 309/322 ; Rank-JIF: 309; Number-of-JIF:322; 5 Year JIF:0.331; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.3; Immediacy Index:0.1; Immediacy Index-dealt:0.129; 2023 JCI:0.04; JCI Rank: 315/322 ; Total Articles:38; JCI Quartile:Q4; JCI Percentile:2.33; Eigenfactor:0; Normalized Eigenfactor:0.075; Article Influence Score:0.075; JIF Percentile:4.2; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:122; % of Articles in Citable items:0.3115; Cited Half-Life:7.7; Citing Half-Life:8.2; % of OA Gold:0.9931; Publisher name:ACADEMIC PRESS INC ELSEVIER SCIENCE; Publisher address:525 B ST, STE 1900, SAN DI
投票 ESCI期刊International Journal of Breast Cancer 2024/2025影响因子:1.686 (INT J BREAST CANCER) (2090-3170). (ONCOLOGY)(肿瘤学)Emer  ...234
Total Citations:517; 2023 JIF:1.686; JIFRank: 253/322 ; Rank-JIF: 253; Number-of-JIF:322; 5 Year JIF:1.939; 5 Year JIF Quartile:Q4; JIF Without Self Cites:1.6; Immediacy Index:1; Immediacy Index-dealt:1.109; 2023 JCI:0.4; JCI Rank: 241/322 ; Total Articles:7; JCI Quartile:Q3; JCI Percentile:25.31; Eigenfactor:0; Normalized Eigenfactor:0.055; Article Influence Score:0.43; JIF Percentile:21.6; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:7; % of Articles in Citable items:1; Cited Half-Life:8.8; Citing Half-Life:6.8; % of OA Gold:1; Publisher name:TAYLOR & FRANCIS LTD; Publisher address:2-4 PARK SQUARE, MILTON PARK, ABINGDON, England, OXON, O
投票 ESCI期刊Radiation Oncology Journal 2024/2025影响因子:1.819 (RADIAT ONCOL J) (2234-3156). (ONCOLOGY)(肿瘤学)Emerging Sources Cita  ...234
Total Citations:722; 2023 JIF:1.819; JIFRank: 241/322 ; Rank-JIF: 241; Number-of-JIF:322; 5 Year JIF:2.131; 5 Year JIF Quartile:Q3; JIF Without Self Cites:1.7; Immediacy Index:0.3; Immediacy Index-dealt:0.349; 2023 JCI:0.38; JCI Rank: 249/322 ; Total Articles:27; JCI Quartile:Q4; JCI Percentile:22.83; Eigenfactor:0.001; Normalized Eigenfactor:0.197; Article Influence Score:0.597; JIF Percentile:25.3; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:32; % of Articles in Citable items:0.8438; Cited Half-Life:5.7; Citing Half-Life:6.9; % of OA Gold:0.9703; Publisher name:OXFORD UNIV PRESS INC; Publisher address:JOURNALS DEPT, 2001 EVANS RD, CARY,
投票 ESCI期刊Current Breast Cancer Reports 2024/2025影响因子:1.137 (CURR BREAST CANCER R) (1943-4588). (ONCOLOGY)(肿瘤学)Emerging Sou  ...234
Total Citations:371; 2023 JIF:1.137; JIFRank: 287/322 ; Rank-JIF: 287; Number-of-JIF:322; 5 Year JIF:1.196; 5 Year JIF Quartile:Q4; JIF Without Self Cites:1; Immediacy Index:0.1; Immediacy Index-dealt:0.104; 2023 JCI:0.18; JCI Rank: 290/322 ; Total Articles:30; JCI Quartile:Q4; JCI Percentile:10.09; Eigenfactor:0.001; Normalized Eigenfactor:0.142; Article Influence Score:0.412; JIF Percentile:11; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:44; % of Articles in Citable items:0.6818; Cited Half-Life:4.9; Citing Half-Life:6.5; % of OA Gold:0.1228; Publisher name:WILEY; Publisher address:111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774;
投票 ESCI期刊NAR Cancer 2024/2025影响因子:3.441 (NAR CANCER) (2632-8674). (ONCOLOGY)(肿瘤学)Emerging Sources Citation Index  ...234
Total Citations:617; 2023 JIF:3.441; JIFRank: 110/322 ; Rank-JIF: 110; Number-of-JIF:322; 5 Year JIF:4.176; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3.3; Immediacy Index:1; Immediacy Index-dealt:1.186; 2023 JCI:0.72; JCI Rank: 139/322 ; Total Articles:53; JCI Quartile:Q2; JCI Percentile:56.99; Eigenfactor:0.002; Normalized Eigenfactor:0.413; Article Influence Score:1.7; JIF Percentile:66; JIF Quartile:Q2; AIS Quartile:Q1; Citable Items:60; % of Articles in Citable items:0.8833; Cited Half-Life:2.6; Citing Half-Life:7.6; % of OA Gold:0.9551; Publisher name:WILEY; Publisher address:111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774;
投票 ESCI期刊European Journal of Breast Health 2024/2025影响因子:1.333 (EUR J BREAST HEALTH) (NULL). (ONCOLOGY)(肿瘤学)Emerging Sourc  ...234
Total Citations:477; 2023 JIF:1.333; JIFRank: 271/322 ; Rank-JIF: 271; Number-of-JIF:322; 5 Year JIF:1.847; 5 Year JIF Quartile:Q4; JIF Without Self Cites:1.3; Immediacy Index:0.3; Immediacy Index-dealt:0.381; 2023 JCI:0.31; JCI Rank: 268/322 ; Total Articles:37; JCI Quartile:Q4; JCI Percentile:16.93; Eigenfactor:0.001; Normalized Eigenfactor:0.198; Article Influence Score:0.456; JIF Percentile:16; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:43; % of Articles in Citable items:0.8605; Cited Half-Life:3.9; Citing Half-Life:9; % of OA Gold:1; Publisher name:INST SOUTHEAST ASIAN STUDIES-ISEAS; Publisher address:30 HENG MUI KING TERACE, PASIR
投票 ESCI期刊Onkologija 2024/2025影响因子:0.181 (ONKOLOGIJA) (1408-1741). (ONCOLOGY)(肿瘤学)Emerging Sources Citation Index  ...234
Total Citations:11; 2023 JIF:0.181; JIFRank: 318/322 ; Rank-JIF: 318; Number-of-JIF:322; 5 Year JIF:0.166; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.1; Immediacy Index:<0.1; Immediacy Index-dealt:0.081; 2023 JCI:0.02; JCI Rank: 319/322 ; Total Articles:5; JCI Quartile:Q4; JCI Percentile:1.09; Eigenfactor:0; Normalized Eigenfactor:0.003; Article Influence Score:0.02; JIF Percentile:1.4; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:8; % of Articles in Citable items:0.625; Cited Half-Life:NULL; Citing Half-Life:3.7; % of OA Gold:0; Publisher name:SPRINGERNATURE; Publisher address:CAMPUS, 4 CRINAN ST, LONDON, ENGLAND, N1 9XW;
投票 ESCI期刊eCancerMedicalScience 2024/2025影响因子:1.259 (ECANCERMEDICALSCIENC) (1754-6605). (ONCOLOGY)(肿瘤学)Emerging Sources Cit  ...234
Total Citations:2158; 2023 JIF:1.259; JIFRank: 273/322 ; Rank-JIF: 273; Number-of-JIF:322; 5 Year JIF:1.973; 5 Year JIF Quartile:Q4; JIF Without Self Cites:1.2; Immediacy Index:0.1; Immediacy Index-dealt:0.161; 2023 JCI:0.36; JCI Rank: 255/322 ; Total Articles:146; JCI Quartile:Q4; JCI Percentile:20.96; Eigenfactor:0.003; Normalized Eigenfactor:0.677; Article Influence Score:0.527; JIF Percentile:15.4; JIF Quartile:Q4; AIS Quartile:Q3; Citable Items:158; % of Articles in Citable items:0.9241; Cited Half-Life:4.9; Citing Half-Life:6.4; % of OA Gold:0.9695; Publisher name:SAGE PUBLICATIONS INC; Publisher address:2455 TELLER RD, THOUSAND OAKS, U
投票 ESCI期刊Molecular & Cellular Oncology 2024/2025影响因子:2.635 (MOL CELL ONCOL) (NULL). (ONCOLOGY)(肿瘤学)Emerging Sources Citati  ...234
Total Citations:1159; 2023 JIF:2.635; JIFRank: 175/322 ; Rank-JIF: 175; Number-of-JIF:322; 5 Year JIF:1.696; 5 Year JIF Quartile:Q4; JIF Without Self Cites:2.6; Immediacy Index:0.3; Immediacy Index-dealt:0.395; 2023 JCI:0.24; JCI Rank: 282/322 ; Total Articles:4; JCI Quartile:Q4; JCI Percentile:12.58; Eigenfactor:0.001; Normalized Eigenfactor:0.237; Article Influence Score:0.463; JIF Percentile:45.8; JIF Quartile:Q3; AIS Quartile:Q4; Citable Items:4; % of Articles in Citable items:1; Cited Half-Life:7.2; Citing Half-Life:7.6; % of OA Gold:0.5227; Publisher name:SAGE PUBLICATIONS INC; Publisher address:2455 TELLER RD, THOUSAND OAKS, USA, CA, 9
投票 ESCI期刊Oncology in Clinical Practice 2024/2025影响因子:0.368 (ONCOL CLIN PRACT) (2450-1654). (ONCOLOGY)(肿瘤学)Emerging Sources  ...234
Total Citations:139; 2023 JIF:0.368; JIFRank: 309/322 ; Rank-JIF: 309; Number-of-JIF:322; 5 Year JIF:0.409; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.3; Immediacy Index:0.1; Immediacy Index-dealt:0.113; 2023 JCI:0.08; JCI Rank: 309/322 ; Total Articles:56; JCI Quartile:Q4; JCI Percentile:4.19; Eigenfactor:0; Normalized Eigenfactor:0.029; Article Influence Score:0.076; JIF Percentile:4.2; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:93; % of Articles in Citable items:0.6022; Cited Half-Life:4.5; Citing Half-Life:6.1; % of OA Gold:0.9829; Publisher name:TAYLOR & FRANCIS INC; Publisher address:530 WALNUT STREET, STE 850, PHILADELPHIA,
投票 ESCI期刊Middle East Journal of Cancer 2024/2025影响因子:0.478 (MIDDLE EAST J CANCER) (2008-6709). (ONCOLOGY)(肿瘤学)Emerging Sou  ...234
Total Citations:201; 2023 JIF:0.478; JIFRank: 304/322 ; Rank-JIF: 304; Number-of-JIF:322; 5 Year JIF:0.581; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.4; Immediacy Index:0.1; Immediacy Index-dealt:0.131; 2023 JCI:0.09; JCI Rank: 307/322 ; Total Articles:58; JCI Quartile:Q4; JCI Percentile:4.81; Eigenfactor:0; Normalized Eigenfactor:0.066; Article Influence Score:0.116; JIF Percentile:5.7; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:64; % of Articles in Citable items:0.9063; Cited Half-Life:4.2; Citing Half-Life:8.9; % of OA Gold:0; Publisher name:SPRINGERNATURE; Publisher address:CAMPUS, 4 CRINAN ST, LONDON, ENGLAND, N1 9XW;
投票 ESCI期刊JNCI Cancer Spectrum 2024/2025影响因子:3.439 (JNCI CANCER SPECT) (NULL). (ONCOLOGY)(肿瘤学)Emerging Sources Citation Ind  ...234
Total Citations:1963; 2023 JIF:3.439; JIFRank: 110/322 ; Rank-JIF: 110; Number-of-JIF:322; 5 Year JIF:4.231; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3.4; Immediacy Index:1.9; Immediacy Index-dealt:1.927; 2023 JCI:0.82; JCI Rank: 109/322 ; Total Articles:83; JCI Quartile:Q2; JCI Percentile:66.3; Eigenfactor:0.008; Normalized Eigenfactor:1.639; Article Influence Score:2.16; JIF Percentile:66; JIF Quartile:Q2; AIS Quartile:Q1; Citable Items:90; % of Articles in Citable items:0.9222; Cited Half-Life:3.3; Citing Half-Life:5.9; % of OA Gold:0.9496; Publisher name:ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD; Publisher address:2-4 PARK SQUARE, MI
投票 ESCI期刊International Journal of Clinical and Experimental Pathology 2024/2025影响因子:1.128 (INT J CLIN EXP PATHO) (1936-262  ...234
Total Citations:8597; 2023 JIF:1.128; JIFRank: 280/322 ; Rank-JIF: 280; Number-of-JIF:322; 5 Year JIF:1.357; 5 Year JIF Quartile:Q4; JIF Without Self Cites:1.1; Immediacy Index:<0.1; Immediacy Index-dealt:0.093; 2023 JCI:0.35; JCI Rank: 258/322 ; Total Articles:34; JCI Quartile:Q4; JCI Percentile:21.02; Eigenfactor:0.004; Normalized Eigenfactor:0.89; Article Influence Score:0.28; JIF Percentile:24.4; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:42; % of Articles in Citable items:0.8095; Cited Half-Life:8.4; Citing Half-Life:6.2; % of OA Gold:0; Publisher name:BRILL; Publisher address:PLANTIJNSTRAAT 2, P O BOX 9000, LEIDEN, NETHERLANDS, 230
投票 ESCI期刊Cancer Drug Resistance 2024/2025影响因子:4.672 (CANCER DRUG RESIST) (NULL). (ONCOLOGY)(肿瘤学)Emerging Sources Citation  ...234
Total Citations:1342; 2023 JIF:4.672; JIFRank: 76/322 ; Rank-JIF: 76; Number-of-JIF:322; 5 Year JIF:4.449; 5 Year JIF Quartile:Q2; JIF Without Self Cites:4.5; Immediacy Index:1; Immediacy Index-dealt:1.121; 2023 JCI:0.61; JCI Rank: 174/322 ; Total Articles:12; JCI Quartile:Q3; JCI Percentile:46.12; Eigenfactor:0.002; Normalized Eigenfactor:0.474; Article Influence Score:0.883; JIF Percentile:76.6; JIF Quartile:Q1; AIS Quartile:Q2; Citable Items:44; % of Articles in Citable items:0.2727; Cited Half-Life:3.1; Citing Half-Life:5.7; % of OA Gold:0.9943; Publisher name:ELSEVIER SCI LTD; Publisher address:125 London Wall, London, England, EC2Y 5AS;
下一页 »
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-1 01:53
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
返回顶部 返回版块